Status:
COMPLETED
Mexican Registry of Pulmonary Hypertension
Lead Sponsor:
Remehip
Collaborating Sponsors:
Medicaweb, S.A.C.V.
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
2-90 years
Brief Summary
Prospective multicenter registry including incident patients and prevalent patients which pretends to identify clinical characteristics, treatment trends in-hospital and four years follow-up outcome t...
Detailed Description
Introduction. Pulmonary hypertension (PH) is a worldwide group of vascular diseases characterized by progressive increase in pulmonary vascular resistance and pulmonary arterial pressure with secondar...
Eligibility Criteria
Inclusion
- Patients older than 2 years with: a) diagnosis of PH (PAH by RHC), b) Groups I and IV
Exclusion
- Severe pulmonary function abnormalities (vital capacity \< 60% predicted, FEV1 \< 50% predicted)
- Abnormal pulmonary capillary wedge pressure (\> 15 mmHg)
- Refusal to participate.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
875 Patients enrolled
Trial Details
Trial ID
NCT02252705
Start Date
July 1 2014
End Date
April 1 2018
Last Update
June 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.